123

Shares

News site default image

Medication Nonadherence Costs Billions in Lost Revenue

Shared by Radhika Narayanan | 1 121 1 | about 1 year ago

HealthPrize Technologies announced the publication of an update to a research paper co-authored with Capgemini estimating annual pharmaceutical revenue losses of $637 billion due to medication nonadherence to medications for the treatment of chronic conditions. Globally, revenue loss has increased from $564 billion in 2012 to $637 billion in 2015, with U.S.-based revenue losses increasing from $188 billion in 2012 to $250 billion in 2015.

Read More On www.pharmpro.com

Categories Digital chemistry & Pharma IT Health economics

Related Post

Links

http://www.pharmpro.com/news/2016/11/medication-nonadherence-costs-billions-lost-revenue
http://www.pharmpro.stfi.re/news/2016/11/medication-nonadherence-costs-billions-lost-revenue?sf=xzxoxod
http://stfi.re/xzxoxod
http://bit.ly/2ggh7h3

0 Votes

You must log in to post a comment

0 Comments